Search - tctmd.com

Displaying 21 - 34 of 34

Sort: Relevancy | Date

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2016

Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical)

Presenter: Emerson C. Perin, William T. Abraham

November 01, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

Presentation TCT 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

First TCT Innovation Award Given for Novel Cooling System

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

Presentation TCT 2014

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

Presenter: Steven R. Bailey, Surya Dharma

September 14, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

Presentation TCT 2012

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Niccoli Giampaolo

October 22, 2012

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

Advertisement

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical)

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Heart Failure Advances (Ivabradine, ARNI, and More)

Companies With Innovative Technologies Compete in TCT Shark Tank

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

First TCT Innovation Award Given for Novel Cooling System

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

Experts Debate Future of Renal Denervation Therapy

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

Caution Urged in Widespread Adoption of TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content